The Alibaba company runs various online commerce platforms, including Tmall. However, the group has demanded vendors stop offering medicine on the platform, as part of a new directive. Albeit these products seem to be genuine, online platforms have to help their drug sales immediately.
When consumers think of online commerce platforms such as the ones operated by Alibaba, the last thing most people would purchase is drugs. Healthcare is a serious business, and consumers should never medicine online, regardless of how legitimate the seller may appear to be.
The China Food and Drug Administration has issued a new directive prohibiting drug sales on third-party platforms effectively immediately. No particular reason was given for this instruction, unfortunately. However, the Chinese government wanted to promote online sales of over-the-counter medicine.
By the look of things, the usage of technology to prevent and address issues related to high drug pricing and growing hospital queues did not go as planned. Public hospitals are the dominant market leader when it comes to over-the-counter medicine sales, and online marketplaces were starting to take their claim over the past few months.
An Alibaba spokeswoman told the media that:
“Tmall cooperating and complying with the government’s new policy to stop online drug sales on third-party platforms. While the policy change might impact the whole medicine e-commerce business including Yao.Tmall.com, industry players are exploring new ways to use internet technology to help improve the traditional drug retail system.”
Reforming China’s healthcare market will not be as easy as originally assumed. Authorities have expressed their concern regarding the challenges of regulation online drug sales. With the over-the-counter market set to double in revenue by 2025, regulatory concerns will need to be addressed sooner rather than later.
Unfortunately, this directive will have a big impact on pharmacy chains active on the Tmall platform. The platform had brought in an additional revenue stream for these businesses, all of whom will now have to look for other ways to offer their drugs in an online fashion. This new directive will send shockwaves through the entire pharmacy industry in China, that much is certain.
Source; Reuters
If you liked this article follow us on Twitter @themerklenews and make sure to subscribe to our newsletter to receive the latest bitcoin and altcoin price analysis and the latest cryptocurrency news.
Recent years have shown an increased interest in investing in cryptocurrencies, and as it stands,…
The crypto world is dynamic, fast-paced, and brimming with opportunities for those willing to take…
Can this new coin Growth Potential energize the market again? SOL fell 20% from its…
Aureal One (DLUME) has attracted considerable interest in its presale stage, with reports of possible…
Three particularly noteworthy altcoins are attracting investors this year-end: Polkadot (DOT), Chainlink (LINK), and the…
The Best New Meme Coins to Join in December 2024: Highlighting BTFD Coin, Popcat, and…